Accordingly, it was possible that some GFPT1‐related CMS patients might exhibit distinctive muscle MRI, and played an adjunctive role in the diagnosis of CMS, specifically in differentiating CMS from myopathic or dystrophic disorders and between CMS subtypes. This evidence concerns the gene GFPT1 and congenital myasthenic syndrome.